Showing results (21-30 of 65) with videos related to
Sort By:
Pageof 7
Journal of Combinatorial Chemistry|July 12, 2005
High-speed synthesis of potent C2-symmetric HIV-1 protease inhibitors by in-situ aminocarbonylationsJohan Wannberg, Nils-Fredrik K Kaiser, Lotta Vrang, et al.Biochimica Et Biophysica Acta|April 2, 2004
Structure-activity relationships for the selectivity of hepatitis C virus NS3 protease inhibitorsAnton Poliakov, Anja Johansson, Eva Akerblom, et al.European Journal of Medicinal Chemistry|November 21, 2009
Design and synthesis of novel P2 substituents in diol-based HIV protease inhibitorsJenny Adrian Meredith, Hans Wallberg, Lotta Vrang, et al.Bioorganic & Medicinal Chemistry|April 20, 2006
A new structural theme in C2-symmetric HIV-1 protease inhibitors: ortho-substituted P1/P1' side chainsJohan Wannberg, Yogesh A Sabnis, Lotta Vrang, et al.European Journal of Medicinal Chemistry|December 10, 2009
P2'-truncated BACE-1 inhibitors with a novel hydroxethylene-like coreJenny Adrian Meredith, Catarina Björklund, Hans Adolfsson, et al.Bioorganic & Medicinal Chemistry|March 5, 2003
Design and synthesis of HIV-1 protease inhibitors. Novel tetrahydrofuran P2/P2'-groups interacting with Asp29/30 of the HIV-1 protease. Determination of binding from X-ray crystal structure of inhibitor protease complexKarin Oscarsson, Martina Lahmann, Jimmy Lindberg, et al.Bioorganic & Medicinal Chemistry|February 4, 2010
Discovery of potent BACE-1 inhibitors containing a new hydroxyethylene (HE) scaffold: exploration of P1' alkoxy residues and an aminoethylene (AE) central coreCatarina Björklund, Hans Adolfsson, Katarina Jansson, et al.Journal of Medicinal Chemistry|December 3, 2002
Relationships between structure and interaction kinetics for HIV-1 protease inhibitorsPer-Olof Markgren, Wesley Schaal, Markku Hämäläinen, et al.Journal of Medicinal Chemistry|October 29, 2013
Design and synthesis of P1-P3 macrocyclic tertiary-alcohol-comprising HIV-1 protease inhibitorsAdvait Joshi, Jean-Baptiste Véron, Johan Unge, et al.Bioorganic & Medicinal Chemistry|November 5, 2002
Tetrapeptides as potent protease inhibitors of Hepatitis C Virus full-length NS3 (protease-helicase/NTPase)Anja Johansson, Anton Poliakov, Eva Akerblom, et al.Pageof 7